<table id="table5" stylecode="Noautorules" width="700" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5 Mean Change in Drug Exposure (AUC<sub>0-∞</sub> and C<sub>max</sub>) when Administered with WELCHOL (3.75 g)<sup>a</sup>
</caption>
<tfoot>
<tr>
<td colspan="8">
<sup>a</sup> With verapamil, the dose of WELCHOL was 4.5 g</td>
</tr>
<tr>
<td colspan="8">
<sup>b</sup> Should be administered at least 4 hours prior to WELCHOL  [See <content stylecode="italics">Drug Interactions</content> (<linkhtml href="#s070">7</linkhtml>)].</td>
</tr>
<tr>
<td colspan="8">
<sup>c</sup> Patients receiving concomitant metformin ER and colesevelam should be monitored for clinical response as is usual for the use of anti-diabetes drugs  [See <content stylecode="italics">Drug Interactions</content> (<linkhtml href="#s070">7</linkhtml>)].</td>
</tr>
<tr>
<td colspan="8">
<sup>d</sup> Cyclosporine levels should be monitored and, based on theoretical grounds, cyclosporine should be administered at least 4 hours prior to WELCHOL [See <content stylecode="italics">Drug Interactions</content> (<linkhtml href="#s070">7</linkhtml>)]. </td>
</tr>
<tr>
<td colspan="8">* Oral contraceptive containing norethindrone and ethinyl estradiol.</td>
</tr>
<tr>
<td colspan="8">N/A – Not Available </td>
</tr>
</tfoot>
<tbody>
<tr>
<td rowspan="2" stylecode="Botrule" valign="middle">
<content stylecode="bold">Drug</content>
</td>
<td align="center" rowspan="2" stylecode="Botrule" valign="middle">
<content stylecode="bold">Dose</content>
</td>
<td colspan="2" stylecode="Botrule" valign="bottom">
<content stylecode="bold">Co-administered</content>
</td>
<td colspan="2" stylecode="Botrule" valign="bottom">
<content stylecode="bold">1 hr prior to<br/>WELCHOL</content>
</td>
<td colspan="2" stylecode="Botrule" valign="bottom">
<content stylecode="bold">4 hr prior to<br/>WELCHOL</content>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule">AUC<sub>0-∞</sub>
</td>
<td align="center" stylecode="Botrule">C<sub>max</sub>
</td>
<td align="center" stylecode="Botrule">AUC<sub>0-∞</sub>
</td>
<td align="center" stylecode="Botrule">C<sub>max</sub>
</td>
<td align="center" stylecode="Botrule">AUC<sub>0-∞</sub>
</td>
<td align="center" stylecode="Botrule">C<sub>max</sub>
</td>
</tr>
<tr stylecode="Botrule">
<td>Cyclosporine</td>
<td align="center">200 mg</td>
<td align="center">-34%</td>
<td align="center">-44%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr stylecode="Botrule">
<td>Ethinyl Estradiol* <sup>b</sup>
</td>
<td align="center">0.035 mg</td>
<td align="center">-24%</td>
<td align="center">-24%</td>
<td align="center">-18%</td>
<td align="center">-1%</td>
<td align="center">-12%</td>
<td align="center">0%</td>
</tr>
<tr stylecode="Botrule">
<td>Glimepiride <sup>b</sup>
</td>
<td align="center">4 mg</td>
<td align="center">-18%</td>
<td align="center">-8%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">-6%</td>
<td align="center">3%</td>
</tr>
<tr stylecode="Botrule">
<td>Glipizide <sup>b</sup>
</td>
<td align="center">20 mg</td>
<td align="center">-12%</td>
<td align="center">-13%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">-4%</td>
<td align="center">0%</td>
</tr>
<tr stylecode="Botrule">
<td>Glyburide <sup>b</sup>
</td>
<td align="center">3 mg</td>
<td align="center">-32%</td>
<td align="center">-47%</td>
<td align="center">-20%</td>
<td align="center">-15%</td>
<td align="center">-7%</td>
<td align="center">4%</td>
</tr>
<tr stylecode="Botrule">
<td>Levothyroxine <sup>b</sup>
</td>
<td align="center">600 µg</td>
<td align="center">-22%</td>
<td align="center">-33%</td>
<td align="center">6%</td>
<td align="center">-2%</td>
<td align="center">1%</td>
<td align="center">8%</td>
</tr>
<tr stylecode="Botrule">
<td>Metformin ER <sup>c</sup>
</td>
<td align="center">1500 mg</td>
<td align="center">44%</td>
<td align="center">8%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr stylecode="Botrule">
<td>Norethindrone* <sup>b</sup>
</td>
<td align="center">1 mg</td>
<td align="center">-1%</td>
<td align="center">-20%</td>
<td align="center">5%</td>
<td align="center">-3%</td>
<td align="center">6%</td>
<td align="center">7%</td>
</tr>
<tr stylecode="Botrule">
<td>Olmesartan Medoxomil<sup>b</sup>
</td>
<td align="center">40 mg</td>
<td align="center">-39%</td>
<td align="center">-28%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">-15%</td>
<td align="center">-4%</td>
</tr>
<tr stylecode="Botrule">
<td>Repaglinide</td>
<td align="center">2 mg</td>
<td align="center">-7%</td>
<td align="center">-19%</td>
<td align="center">-6%</td>
<td align="center">-1%</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr stylecode="Botrule">
<td>Verapamil sustained-<br/>release</td>
<td align="center" valign="middle">240 mg </td>
<td align="center" valign="middle">-31%</td>
<td align="center" valign="middle">-11%</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">N/A</td>
</tr>
</tbody>
</table>